Maintenance intravenous iron in hemodialysis patients to minimize erythropoietin doses: a double-blinded, randomized controlled trial (the MAINTAIN IRON trial).

Anumas S, Chatkrailert A, Tantiyavarong P

Open source

DOI
10.1038/s41598-023-28440-3
Published
2023 Jan 23
Container
Scientific reports
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41598-023-28440-3,
  title = {Maintenance intravenous iron in hemodialysis patients to minimize erythropoietin doses: a double-blinded, randomized controlled trial (the MAINTAIN IRON trial).},
  author = {Anumas S and Chatkrailert A and Tantiyavarong P},
  year = {2023},
  journal = {Scientific reports},
  doi = {10.1038/s41598-023-28440-3},
  url = {https://doi.org/10.1038/s41598-023-28440-3}
}

RIS

TY  - JOUR
TI  - Maintenance intravenous iron in hemodialysis patients to minimize erythropoietin doses: a double-blinded, randomized controlled trial (the MAINTAIN IRON trial).
AU  - Anumas S
AU  - Chatkrailert A
AU  - Tantiyavarong P
PY  - 2023
JO  - Scientific reports
DO  - 10.1038/s41598-023-28440-3
UR  - https://doi.org/10.1038/s41598-023-28440-3
ER  - 

APA

S, A., A, C., & P, T. (2023). Maintenance intravenous iron in hemodialysis patients to minimize erythropoietin doses: a double-blinded, randomized controlled trial (the MAINTAIN IRON trial).. Scientific reports. https://doi.org/10.1038/s41598-023-28440-3

Source records